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BACKGROUND: The conventional magnetic resonance imaging (cMRI) and apparent diffusion coefficient (ADC) may have a role in predicting 
tumor grade for gliomas and may in turn assist in identifying 
tumor biopsy sites. In this study, we aimed to determine 
the added value of a joint approach of diffusion-weighted 
imaging (DWI) and cMRI to determine of low grade and 
high-grade glioma, compare to cMRI alone.
METHODS: Data were collected from 56 glioma patients, 
who underwent examinations and received treatment at 
Cipto Mangunkusumo National Central General Hospital, 
Jakarta, Indonesia, from the period of 2015–2018. Inclusion 
criteria was patients who underwent cMRI with a DWI-
ADC sequence and patient that were diagnosed with 
glioma according to the histopathological results. Pathology 
reports of the imaging results were reviewed independently. 
A receiver operator curve (ROC) analysis assessed the 
predictive potential of cMRI and ADC values for low-grade 
and high-grade gliomas.
RESULTS: Fifty-six subjects met the inclusion criteria. The 
combination of MRI and ADC values increased sensitivity 
(to 90%) and negative predictive value (to 92.9%), and also 
improved the negative likelihood ratio (to 0.14).  However, 
the combination of MRI and ADC values had the highest 
area under the curve (78.6%) and sensitivity (78.6%), which 
was similar to the separated examination.
CONCLUSION: The combination of ADC value and 
conventional MRI increases sensitivity in differentiating 
low-grade and high-grade glioma compared to separated 
examination.
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Abstract
Introduction
Gliomas are the most common primary brain tumors 
in adults. Glial tumors are made up of astrocytomas, 
oligodendrogliomas, mixed oligo-astrocytic, and mixed 
glioneuronal tumors, which arise from the supporting glial 
cells of the central nervous system (CNS).(1) According 
to the Central Brain Tumor Registry of the United States 
(CBTRUS) Statistical Reports, there were 392,982 cases of 
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brain tumors reported from 2011 to 2015. Gliomas account 
for 26% of all primary brain tumors and 81% of malignant 
CNS tumors.(2) Glioma grading has an important role in 
treatment strategies because high-grade gliomas after 
resection are treated with adjuvant radiation therapy or 
chemotherapy, while low-grade gliomas are not.(3,4) To 
diagnose glioma, histopathological examination remains 
the gold standard. Based on histopathologic characteristics 
such as cytological atypia, anaplasia, mitotic activity, 
microvascular proliferation and necrosis, The World Health 
Organization (WHO) classification system categorizes 
gliomas from grade I through grade IV.(1) However, 
some diagnostic  difficulties  arise  from  sampling  and 
overlapping features leading to an underestimation of tumor 
grade, especially for high-grade lesions. These limitations 
are motivating research into non-invasive imaging 
techniques.(5–7)
 As for imaging, conventional contrast-enhanced 
magnetic resonance imaging (MRI) is the gold standard 
non-invasive technique.(5,6) However, the classification 
and grading of gliomas with conventional MRI is reportedly 
unreliable due to its sensitivity, which ranges from 55.1% to 
83.3%.(8)
 In a previous study, it is stated that the apparent 
diffusion coefficient (ADC) tumor value provides more 
adequate data than conventional MRI, reflecting a suitable 
histopathological grade.(9) With the advent of technology, 
multiparametric MRI can demonstrate physiology and 
molecular properties of the brain with the ADC.(10) Also, 
multiparametric MRI increases the accuracy of brain tumor 
diagnoses.(11) Several studies have reported a correlation 
between tumor and ADC values.(9,12,13) The ADC 
sequence is based on water molecules diffusion within the 
tissue. Normal and diseased brain areas have different ADCs 
because of the brain microarchitecture heterogeneity. The 
higher diffusion of brain tissue, the higher the value of ADC. 
Therefore, the ADC value can identify issues quantitatively.
(7) If ADC can predict cellularity and tumor grade, ADC 
value combined with conventional MRI will likely be useful 
in improving prediction of glioma grade. In this study, by 
combining cMRI and ADC imaging, it is expected to 
increase the diagnostic value comparing to cMRI alone, and 
it can help in determining the next therapeutic action.
Methods
This study has obtained institutional review board 
approvals from the Health Research Ethics Committee, 
Faculty of Medicine, Universitas Indonesia (No. 0529/
UN2.F1/ETIK/2018) and the Health Research Ethics 
Committee Cipto Mangunkusumo National Central General 
Hospital (No. LB.02/2.2.1/0585/2018), for the cMRI and 
Anatomic  Pathology   patient   data   collection   at   Cipto 
Mangunkusumo  National Central  General  Hospital, 
Jakarta, Indonesia.
Study Design
This was a retrospective analytic study, conducted between 
2015-2018. A diffusion-weighted imaging (DWI)-ADC data 
from head MRI were obtained, and their association with 
low- and high-grade gliomas, based on histopathological 
examination, were investigated to evaluate the relationships 
between data. 
 Two-hundred-ninety-two patients with a clinical 
susceptibility of space-occupying lesion underwent 
examinations and received treatment at Cipto 
Mangunkusumo National General Hospital. Inclusion 
criteria was patients who underwent cMRI with a DWI-
ADC sequence and patient that were diagnosed glioma 
according to histopathological results. Exclusion criteria 
was patient that were not diagnosed glioma according 
to histopathological results. Patients whose diagnosis 
was not a brain tumor based on MRI and glioma based 
on histopathology, or who had incomplete examination 
results or no tumor were excluded. As much as 236 patients 
met exclusion criteria with the majority classified as 
meningioma (n = 96) and hypophyseal adenoma (n = 51), 
followed by sellar region tumor (n = 16), embryonal tumors 
(n = 14), metastatic tumors (n = 13), schwannoma (n = 12), 
lymphomas (n = 6), neuronal and mixed neuronal-glial 
tumor (n = 5), ependymal tumors (n = 4), germ cell tumors 
(n = 4), mesenchymal tumors (n = 3), choroid plexus tumors 
(n = 3), and other lesions which were not classified in the 
WHO Classification of Tumors of the Central Nervous 
System 2016 (n = 9).
Materials
All patients underwent MRI using MRI Siemens 1.5 Tesla 
Avanto (Siemens, Berlin, Germany). MRI images include: 
T2-weighted image (T2WI): (time repetition (TR)/time echo 
(TE) 5160/112 ms, section thickness 5 mm; intersection gap 
1 mm; matrix 269 × 384; field of view (FOV) 20.1 cm × 
23.0 cm). T1-weighted image (T1WI): (TR/TE 500/9.4 ms, 
section thickness 5 mm; intersection gap 1 mm; matrix 256 
× 256; FOV 23.0 cm × 23.0 cm). T1WI was performed in all 
patients. T2-weighted-Fluid-Attenuated Inversion Recovery 
(T2 FLAIR) (TR/TE 7000/92 ms; inversion time 2214.1 
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ms; section thickness 5 mm; intersection gap 1 mm; matrix 
230 × 256; FOV 23.0 cm × 23.0 cm). DWI was obtained in 
the axial plane (TR/TE 4000/97, section thickness 5 mm, 
intersection gap 1, matrix 128 × 128; FOV 23.0 cm × 23.0 
cm).
 DWIs were obtained with b values of 0, 500, and 1000 
mm2/s. The ADCmin value was determined by placing the 
regions of interest (ROI) using a workstation (Syngo MR 
Workplace, Munich, Germany); the placement of five ROI 
spots was done by one researcher. For DWI identification, 
tumors with hyperintense lesions were chosen, whereas 
tumors with a hypointense lesion were identified for ADC 
measurement. ROI placement was done carefully with 
regard to the visual image of the tumor, for an area of 1.6 
mm2. After that, the lowest value for ADC in mm2/s was 
obtained.
Glioma Diagnosis
Glioma diagnosis was based on histopathological criteria 
according to the WHO Classification of Tumors of the 
Central Nervous System 2016.(14) Tumors were assessed 
as WHO grade I, II, III, and IV. The morphology codes for 
malignancy were based on the International Classification 
of Diseases for Oncology (ICD-O) [742A]. For statistical 
purposes, WHO grade I and II tumors were grouped as low-
grade tumors, while WHO grade III and IV tumors were 
grouped as high-grade tumors.
MRI Scoring
The Dean criteria were used for conventional MRI scoring 
by evaluating midline shift, presence of edema, tumor 
hemorrhage, tumor border, presence of cyst and necrotic 
tissue, and presence of a mass effect. Each of these points 
was given a weighing score of 0–2, with an overall minimum 
score of zero and maximum score of 14.
Statistical Analysis
Brain tumor diagnoses were found in the medical records, 
MRI and DWI-ADC results, and histopathological results. 
Data were then analyzed using the Statistical Package for 
the Social Sciences (SPSS) version 20 (IBM Corporation, 
New York, USA), and the cut-off point of each variable was 
determined using Microsoft Excel (Microsoft, Washington, 
USA) to differentiate low- and high-grade gliomas. 
Sensitivity, specificity, accuracy, positive predictive value 
(PPV), negative predictive value (NPV), positive likelihood 
ratio (LR+), and negative likelihood ratio (LR-) were 
calculated.
Results
This was an analytical study with a cross-sectional design 
from the MRI data of brain tumor patients, with ADCmin 
and ADCmax. Fifty-six patients with gliomas were included 
in the statistical analyses. The conventional MRI scans of 
low grade and high-grade gliomas were demonstrated in 
Figure 1 and Figure 2. The histopathological findings that 
provided a diagnosis were demonstrated in Figure 3.
 
Characteristics of Subjects
In this study, the low-grade and high-grade glioma 
proportions were equal (50%). Diffuse astrocytoma and 
glioblastoma made up the largest proportion of gliomas (n 
= 16, 28.6%), followed by pilocytic astrocytoma (n = 16, 
28.6%) (Table 1).
 The Dean criteria showed that giant cell glioblastomas 
had the lowest mean, ADCmin, and ADCmax values and 
the highest Dean criteria score in all types of glioma while 
pilocytic astrocytoma had the highest mean of ADCmin 
and ADCmax value. Pilocytic astrocytoma from low-grade 
glioma had the lowest Dean criteria score.
 Table 2 showed cut off and odds ratio for each 
examination. An independent t-test identified the association 
between mean and median, which were independent 
variables, and tumor type according to histopathology. 
There was a significant difference between all the mean of 
ADCmin, ADCmax, and conventional MRI scores between 
the low-grade and high-grade groups (p<0.05).
Receiver Operating Characteristic (ROC) Curve and 
Area Under the Curve (AUC)
In this study, a diagnostic test was carried out by creating a 
ROC curve. Moreover, the AUC was analyzed to measure 
whether a variable was optimal as a marker for low- or 
high-grade gliomas. AUC analysis showed that ADCmin 
and ADCmax and conventional MRI had optimal value 
as markers for high-grade gliomas. According to the ROC 
curve, an optimal cut-off was obtained with the highest 
sensitivity and specificity of each variable. Glioma grades 
were categorized based on their optimal cut-off. Data 
were analyzed with cross-tabulation. From these tables, 
all diagnostic values for each variable were calculated, 
including sensitivity, specificity, accuracy, PPV, NPV, LR+, 
and LR-. Figure 4 showed three ROC curves, which were 
constituted of the ROC curve of separated examination, 
ROC curve of two-parameter combination, and ROC curve 
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Figure 2. High grade glioma (WHO Grade III). A: T1-weighted image (T1WI); B: T2-weighted image (T2WI); C: Fluid-Attenuated 
Inversion Recovery (FLAIR); D: T1WI-post contrast; E: diffusion-weighted imaging (DWI); F: DWI; G: tumoral apparent diffusion 
coefficient (ADC); H: peritumoral ADC.
Figure 1. Low grade glioma (WHO Grade II). A: T1-weighted image (T1WI); B: T2-weighted image (T2WI); C: Fluid-Attenuated 
Inversion Recovery (FLAIR); D: T1WI-post contrast; E: diffusion-weighted imaging (DWI); F: tumoral apparent diffusion coefficient 
(ADC).





Figure 3. The histopathological findings 
of diffuse astrocytoma (WHO Grade II) 
and  glioblastoma (WHO Grade IV) based 
on hematoxylin and eosin staining result. 
A: diffuse astrocytoma, moderately cellular 
tumor consist of proliferating neoplastic 
astrocytes;   B: diffuse astrocytoma, some of 
tumor cells show gemistocytic morphology 
with abundant glassy eosinophilic cytoplasm 
(arrow);  C: glioblastoma, moderate to highly 
cellular tumor (middle) with areas of necrosis 
(asterisks); D: glioblastoma, tumor cells 
show astrocytic differentiation, some with 











    Diffuse Astrocytoma 16 (28.6) 8.7±2.8 1058±452 1310±394.4
    Pilocytic Astrocytoma 9 (16.1) 6.6±3.4 1088.2±286 1354.8±306.8
    Pleiomorphic Xanthoastrocytoma 2 (3.6) 11±1.4 857±173.9 1292±65.8
    Oligondendroglioma, NOS 1 (1.8) 9 786 1033
High-grade Glioma
    Glioblastoma 16 (28.6) 10.4±1.9 621.5±248.2 851.6±254.3
    Anaplastic Astrocytoma 4 (7.1) 11.25±1.3 644±292.6 937.5±316.3
    Anaplastic Oligodendroglioma 4 (7.1) 8±2.4 834±147 976±210.4
    Anaplastic Oligoastrocytoma 3 (5.4) 7±2 752.7±147.0 988±210.4
    Giant Cell Glioblastoma 1 (1.8) 12 361 503
Table 1. Glioma classification and variation of examination results (n=56).
ADC: apparent diffusion coefficient; ADCmin: minimum ADC; ADCmax: maximum ADC, MRI: magnetic 
resonance imaging; NOS: not-otherwise-specified.
of three-parameter combination. From these ROC curves, 
AUC values for low-grade glioma were greater than the 
reference line (50%) with the highest AUC from separated 
examination at 80.4% (p<0.0001; 95%CI: 68.2–92.5%) and 
space-occupying combination at 78.6% (p<0.0001; 95%CI: 
66.1–91.1%), and three-parameter combination at 78.6% 
(p=0.001, 95%: CI 63.9–89.7%) (Table 3).
 The ROC of the three-parameter combination had a 
higher peak for sensitivity and specificity compared to a 
single examination. However, exact calculation and cross-
tabulation have been executed to determine the diagnostic 
properties of each examination. Both separated and combined 
examination had ROCs that were above the reference line 
(50%), which indicated that both examinations had good 
potential for glioma diagnostic and grading examination.
 From Table 4, it can be seen that all separated or 
combined examinations have statistically significant AUC 
values. However, we found that the combined examination 
did not improve AUC values.
Combinations for Low-Grade Tumor Markers
Bivariate analysis was carried out in each variable, 
which met the requirement for multivariate analysis 
determination (p<0.25). Logistic regression analysis with 






cMRI >9.5 17(60.7) 8(28.6)
≤9.5 11(39.3) 20(71.4)
ADC min (x10-3 mm2/s) ≤888.5 21(77) 6(22)
>888.5 7(24) 22(76)






OR (95% CI) aOR (95% CI)
3.8(1.2-11.8) (-)
Table 2. Cut off and odds ratio for each examination.
OR: odds ratio; 95% CI: 95% confidence interval; aOR: adjusted odds ratio.
Figure 4.  The receiver operating curve (ROC) of separated examination and combined examination as a parameter for high-grade 
glioma.
a stepwise backward method was done. However, neither 
variable meets the required p-value (p≤0.05). Therefore, 
the diagnostic value could only be analyzed using cross-
tabulation for the combined examination variables. Low- 
and high-grade tumor diagnoses were categorized with 
combinations of markers. The single examination cMRI 
can diagnosed 17 subjects for low-grade gliomas and 20 
subjects for high-grade glioma. Whereas a combination 
of cMRI and ADC examination can diagnose 26 subjects 
of low-grade gliomas and 20 subjects for high-grade 
gliomas. These were based on conjunction (Λ: AND) and 
disjunction (V: OR) of logical operation between two and 
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Mean±SD Median (Min-Max) p -value*
Total 9.0±2.8 10 (1-13)
Low-grade 8.2±3.1 9 (1-13)
High Grade 9.9±2.3 10 (5-13)
Total 851.7±369.1 858 (103-1907)
Low-grade 1043.7±376.5 972.5 (103-1907)
High Grade 659.8±243.6 614.5 (343-1214)
Total 1098.5±367.6 1059 (503-2227)
Low-grade 1313.2±343.5 1295 (666-2227)








Table 3. Proportion comparison in low-grade and high-grade glioma.
*Unpaired t-test between low- and high-grade glioma for each variable. cMRI: 
conventional magnetic resonance imaging; ADCmin: minimum apparent diffusion 
coefficient (ADC); ADCmax: maximum ADC.  
three different variables. Cross-tabulation determined the 
diagnostic values by comparing histopathological grading 
according to the WHO Classification as the gold standard to 
various parameters, including the combination of ADCmin, 
ADCmax, and conventional MRI as the test variables.
 The combination of (ADCmin Λ ADCmax) Λ cMRI 
had the highest sensitivity (90%), accuracy (78,6%) and 
NPV (92.9%) and the lowest LR- (0.14) compared to 
single examination cMRI which showed lowest sensitivity 
(64.5%), accuracy (66.1%) and the highest LR- (0.52). The 
separated examination. ADCmin V ADCmax indicated 
that if one marker shows positive results for high-grade 
glioma, it could be identified as a high-grade glioma. Then, 
the conjunction combination of (ADCmin V ADCmax) Λ 
cMRI indicated that only if both parameters show positive 
results for high-grade glioma, it can be identified as high-
grade glioma. A combination of (ADCmax V ADCmin) 
V cMRI had the highest PPV (89.3%) compared to the 
separated examination. Among the separated and combined 
examinations, tumoral ADCmax had the highest specificity 
(81.5%), accuracy (80.36%), and LR+ (4.28).
 The combined examination had the lowest negative 
likelihood ratio (0.14), which was the nearest value to 0. 
The lower the ratio, the higher the probability that a high-
grade glioma would not be found in patients without 
clinical features. Likelihood ratios were not influenced 
by prevalence and could be used in various population 
settings. On the other hand, the positive likelihood ratio 
of the combined examinations group had the highest value 
at 3.99, which indicates that the diagnosis of high-grade 
glioma was 3.99 times more likely to happen in a patient 
with clinical features than it would in patients without the 
clinical features.
Discussion
The diagnosis of glioma was categorized according to the 
WHO classification. In this study, glioblastoma and diffuse 
astrocytoma accounted for almost a third of all glioma.  In 
a recent study reported that glioblastoma represents 29.16% 
of all gliomas.(7) However, this finding was different from 
the CBTRUS Statistical Report data in the USA from 2011 
to 2015. According to the study, the proportions of glioma 
consists of 56.6% glioblastoma, 9.5% diffuse astrocytoma, 
6.2% oligodendroglioma, 5.9% anaplastic astrocytoma, 
5.1% pilocytic astrocytoma and all other glioma.(2)
 Two most important predictors of tumor grade were 
mass effect and necrosis.(15) It has been reported that 
conventional MRI is highly accurate at differentiating 
tumor grade in primary brain tumors. The study involved all 
primary brain tumors with a glioma proportion of 91.5% or 
above. The presence of necrosis and contrast enhancement 
is the best feature in conventional MRI to predict tumor 
grade (sensitivity 95.9%, specificity 70%).(8)
 Even though conventional MRI alone has been widely 
used as a gold standard non-invasive technique to diagnose 
brain tumors, it is unreliable for differentiating low-grade 
and high-grade gliomas.(4,7,16) The use of the Dean 
criteria alone, however, has some limitations. Necrosis 
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Examination Se Sp Acc PPV NPV LR+ LR-
Single Examination
    Conventional MRI 64.5% 68.0% 66.1% 71.4% 60.7% 2.02 0.52
    Tumoral ADCmin 75.9% 77.8% 76.8% 78.6% 75.0% 3.41 0.31
    Tumoral ADCmax 79.3% 81.5% 80.4% 82.1% 78.6% 4.28 0.25
Combined Examination
    ADCmin ˄ ADCmax 78.6% 78.6% 78.6% 78.6% 78.6% 3.67 0.27
    ADCmin ˅ ADCmax 76.7% 80.8% 78.6% 82.1% 75.0% 3.99 0.29
    (ADCmin ˄ ADCmax) ˄ cMRI 90.0% 72.2% 78.6% 64.3% 92.9% 3.24 0.14
    (ADCmin ˄ ADCmax) ˅ cMRI 61.5% 76.5% 66.1% 85.7% 46.4% 2.62 0.5
    (ADCmin ˅ ADCmax) ˄ cMRI 85.7% 71.4% 76.8% 64.3% 89.3% 3.00 0.2
    (ADCmin ˅ ADCmax) ˅ cMRI 62.5% 81.2% 67.9% 89.3% 46.4% 3.33 0.46
    cMRI ˄ ADCmin 60.7% 35.7% 48.2% 60.7% 47.6% 0.94 1.10
    cMRI ˄ ADCmax 75.0% 32.1% 53.0% 51.0% 56.0% 1.11 0.78
Table 4. Area under the curve (AUC) comparison of separated and combined examination.
ADCmin: minimum apparent diffusion coefficient (ADC); ADCmax: maximum ADC: cMRI conventional 
magnetic resonance imaging; AUC: area under curve; Se: sensitivity; Sp: specificity; Acc: accuracy; PPV: 
positive predictive value; NPV: negative predictive value; LR+: positive likelihood ratio; LR-: negative 
likelihood ratio; ˄: conjunction; ˅: disjuction.
and hemorrhage could be related to signal heterogeneity 
of the lesion. Mass effect is not necessarily associated with 
the histological grade. Ill-defined tumor border has also 
been reported in lower-grade glioma, and a well-defined 
border has  conversely  been  reported  in  glioblastoma.
(8) The lesion in glioma frequently showed similar contrast 
enhancement, surrounding edema, and mass effect. Some 
low-grade lesions might demonstrate mild edema, minimal 
contrast enhancement, or no mass effect, which can be 
mistakenly interpreted as high-grade gliomas. It has been 
reported that 20% of low-grade gliomas show partial 
contrast enhancement.(16) Conversely, in another study, 
almost one-fifth of glioblastomas did not show contrast-
enhancement.(3)
 The ADCmin was significantly lower in the high-
grade glioma group than in the low-grade glioma group 
(p<0.0001). This finding is consistent with previous 
literatures.(4,7,17–19) However, the cut-off between low- 
and high-grade glioma and the mean ADC value in each 
group have been found to be variable.(7,17,19) It has been 
reported that the cut-off value for mean ADC to discriminate 
low-grade glioma from high-grade glioma is 1.185 × 10-3 
mm2/s, with comparable sensitivity to our findings (97.6%).
(19) The range of the ADCmin value of low- and high- grade 
groups are similar to the results published by a recent study. 
(1,470±0.46 × 10-3 mm2/s for low grades and 470±0.38 × 
10-3 mm2/s for high grades.(17) In previous study reported 
that the mean and ADCmin values of low-grade gliomas 
are 678.73±208.52 × 10-3 mm2/s and 373.75±257.06 × 10-3 
mm2/s respectively.(7) These variations can arise from 
the difference of both low- and high-grade proportions 
of all gliomas, difference in sample size, and pathology 
heterogeneity. 
 Higher ADC values in lower-grade gliomas represent 
higher water content in the interstitial spaces. Thus, glioma 
with higher cellularity shows markedly increased signal 
intensity on DWI and a significant reduction in ADC values.
(4) Even though it is less common in the case of brain 
imaging, artifacts can be affecting images produced by DWI 
and ADC. Following standard protocols can overcome these 
limitations.(7)
 The combination of conventional MRI and DWI-
ADC features in glioma grade differentiation has been 
investigated. This study used ADCmin and ADCmax from 
DWI and the Dean criteria from conventional MRI. The 
use of conventional MRI and DWI might provide useful 
information and be reliable and feasible for glioma grading 
in a more limited facility setting and developing countries. 
Many studies have investigated the diagnostic accuracy of 
conventional MRI combined with multiparametric imaging 
in discriminating tumor grade. It is reported in these previous 
studies that multiparametric MRI can add diagnostic value 
in combination with conventional MRI compared with the 
use of conventional MRI alone.(8,15,19,20)
 However, there are still limited studies that have 
combined only ADC features and conventional MRI. 
Relative ADC (rADC) has been reported to increase 
diagnostic accuracy in combination with conventional 
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MRI features alone (sensitivity of 95.9% to 98.9% and 
specificity of 70% to 75.9%). The ratio of averaged ADCs 
between tumors and normal areas determined the relative 
ADC value.(8) In a contrast-enhancing tumor, the value of 
ADCmin can add useful information to conventional MRI 
findings. It has been stated that pilocytic astrocytoma has a 
cut-off value of 1.5 × 10-3 mm2/s for the differentiation of 
high-grade glioma. This result is slightly different from our 
findings and is possibly due to the difference in sample size 
and variables that are analyzed.(18)
Conclusion
The combination of ADC value and conventional MRI is 
predictive for high-grade glioma. It was found that compared 
to separated examination, the combination of conventional 
MRI and advanced MRI improves sensitivity (to 90%), PPV 
(to 89.3%), NPV (to 92.9%), and negative likelihood ratio 
(to 0.14) in differentiating high-grade glioma from low-
grade glioma.
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